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Multiple exposures to blood transfusions can result in significant hepatic toxicity from 
viral infections and iron overload.’ This toxicity is cumulative and can be the limiting 
factor in an otherwise successful prophylactic transfusion regimen for specific compli- 
cations of sickle cell disease which are both recurrent and life-threatening. This study 
was undertaken to determine the extent of hepatotoxicity in such patients and the value 
of magnetic resonance imaging (MRI)  in its evaluation. 
METHODS 
Subjects of this study were 17 individuals with S S  hemoglobinopathy, whose ages 
ranged from 30 to 231 months (median 125). There were 12 males; indications for 
transfusions were splenic sequestration and stroke. Patients received one to two units of 
blood every three to four weeks as previously described.2 After obtaining informed 
consent, all subjects had percutaneous needle liver biopsies. Iron was quantitated by 
atomic flame spectrophotometry, and reported in micrograms per gram dry weight. 
TABLE 1. Statistical Correlations: MRI Findings 
Liver/Muscle TI/T2 Liver Serum 
Liver Pathology” SIR Liver FF Ferritin 
r 0.72 0.58 0.002 0.63 0.82 
Duration of transfusion p <O.OOl t0.002 NS’ t0.01 <0.001 
n 17 15 15 17 17 
Summated pathologic score. 
*NS is not significant. 
“Address correspondence to Dr. Sarnaik at The Children’s Hospital of Michigan, Comprehen- 
sive Sickle Cell Center, 3901 Beaubieu Boulevard, Detroit, Michigan 48201. 
460 
SARNAIK et al.: IRON OVERLOAD 461 
TABLE 2. Pathologic Changes in Liver Biopsies: Severity Scores 
Hepatocyte Total Patient 
Number Hepatocyte Kupffer Fibrosis Infiltrates Swelling Score 
1 3 4 N A  N A  1 N A  
2 3 2.5 1 0 1 7.5 
3 3 3 1 1 1 9.0 
4 3.5 4 2 3 0 12.5 
5 2.5 3.5 3 2 2 13.0 
6 3 4 1 1 1 10.0 
7 2 2.5 0 0 0 4.5 
8 3 3 3 1 2 12.0 
9 1 1 0 1 2 5.0 
10 2.5 3 I 0 0 6.5 
I 1  3 4 2 2 2 13.0 
12 2.5 2 0 1 1 6.5 
13 2 3 1 2 2 10.0 
14 1 1 0 0 1 3.0 
I5 3 4 2 1 1 11.0 
16 I 2 0 0 1 4.0 
17 1 1 0 0 I 3.0 
Hernosiderosis Portal 
Biopsy specimens were scored blindly for degree of hemosiderosis, fibrosis, and 
hepatocyte swelling by a single pathologist. MRI scans were performed at  a mean time 
to biopsy of 1.9 months, using a Diasonics MT/S superconductive magnet. Liver to 
muscle signal intensity ratios (SIR) were calculated. Serum ferritin was measured 
with a mean time to biopsy of 3 months, using enzyme immunoassay kits 
(Hybridtech). 
RESULTS 
Transfusion duration significantly correlated with liver iron, serum ferritin, SIR, 
and summated pathologic score. There was, however, no correlation with T1 or T 2  
relaxation times or their ratio (TABLE 1). Although there was good correlation between 
SIR and liver iron ( r  = 0.58, p < 0.002), SIR could not differentiate between liver 
irons of 150 and 400 micrograms/mg. Histopathology showed significant hemosidero- 
sis in all patients; portal fibrosis indicating various degrees of cirrhosis was seen in 
more than half the cases (TABLE 2). 
DISCUSSION 
Liver damage reflected by a pathologic score could be significantly related to 
transfusion duration, indicating cumulative hepatitis and iron loading. MRI was not 
adequate to quantitate liver iron, and may not be a good tool for the long-term 
follow-up of patients undergoing chelation therapy. Patients with sickle cell anemia 
who are on prophylactic transfusion regimens are a t  risk for developing severe liver 
damage. Two patients in this series did, in fact, have cirrhotic changes (grade 3 
fibrosis). The benefits of transfusion regimens must thus be weighed against these 
demonstrated risks. and clinicians must make decisions to discontinue transfusions 
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based on the severity of demonstrated toxicity. The risks of the “gold standard” of liver 
biopsy obviate its routine use, and newer, non-invasive technology such as MRI should 
continue to be evaluated for its usefulness in evaluating liver toxicity. 
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